![Dennis Brown](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Brown
Président chez
CELL SOURCE, INC.
Fortune : 11 559 $ au 31/07/2026
Profil
Dennis M.
Brown was the founder of Matrix Pharmaceutical, Inc. (1985), serving as Vice President-Discovery Research from 1995 to 1999.
Dr. Brown is the founder of ChemGenex Therapeutics, Inc. (1999).
Dr. Brown is the founder of Mountain View Pharmaceuticals, Inc. (2000), serving as Chairman since 2000.
Dr. Brown was the founder of ChemGenex Pharmaceuticals Pty Ltd. (2004), serving as President & Executive Director in 2009.
Dr. Brown was the founder of Kintara Therapeutics, Inc. (2009), serving as Chief Scientific Officer from 2018 to 2023.
Dr. Brown is the founder of Del Mar Pharmaceuticals (BC) Ltd. (2010), serving as Director & Chief Scientific Officer since 2013.
Dr. Brown is Executive Chairman at Cell Source, Inc. since 2015.
Dr. Brown is Chairman & Chief Scientific Officer at Edison Oncology Holding Corp.
since 2018.
Dr. Brown is Director at Azora Therapeutics, Inc. Dr. Brown is Director at Medasystems, Inc. Dr. Brown is Member-Research Roundtable at National Brain Tumor Society, Inc. Dr. Brown is President at Valent Technologies LLC since 2020.
Dr. Brown was Managing Director at EGB Ventures LLC.
Dr. Brown was Director at NewGen Therapeutics, Inc. Dr. Brown was Independent Director at Rakovina Therapeutics, Inc. from 2021 to 2026.
Dr. Brown was Assistant Professor-Radiology at Harvard Medical School.
Dr. Brown was Associate at Stanford University School of Medicine.
Dr. Brown completed an undergraduate degree at New York University in 1971.
Dr. Brown completed a graduate degree at New York University in 1975.
Dr. Brown completed a doctorate at New York University in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELL SOURCE, INC. 0,5 % | 17/06/2024 | 6 667 ( 0,5 % ) | 5 934 $ | 31/07/2026 |
| 21/05/2025 | 62 500 ( 0,3 % ) | 5 625 $ | 31/07/2026 |
Postes actifs de Dennis Brown
| Sociétés | Poste | Début |
|---|---|---|
| CELL SOURCE, INC. | Président | 18/05/2015 |
Medasystems, Inc.
 Medasystems, Inc. Packaged SoftwareTechnology Services Operates as a expanded access platform for pharmaceutical manufactures | Directeur/Membre du Conseil | - |
Azora Therapeutics, Inc.
 Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Directeur/Membre du Conseil | - |
National Brain Tumor Society, Inc.
 National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a foundation focused on brain tumors | Corporate Officer/Principal | - |
Valent Technologies LLC | President | 01/03/2020 |
Mountain View Pharmaceuticals, Inc.
 Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical drugs | Fondateur | 01/01/2000 |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Fondateur | 02/04/2010 |
Edison Oncology Holding Corp.
 Edison Oncology Holding Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for anti tumors | Président | 01/10/2018 |
Anciens postes connus de Dennis Brown
| Sociétés | Poste | Fin |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/01/2026 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Dennis Brown
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Health Technology |
Kintara Therapeutics, Inc.
 Kintara Therapeutics, Inc. BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
Cell Source, Inc.
 Cell Source, Inc. BiotechnologyHealth Technology Develops cell therapy treatments | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mountain View Pharmaceuticals, Inc.
Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical drugs | Health Technology |
EGB Ventures LLC
 EGB Ventures LLC Investment ManagersFinance EGB Ventures invests in companies located across the globe. The firm targets companies operating in the fields of pharmaceutical sectors. It participates in early stage capital requirements. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Brain Tumor Society, Inc.
National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a foundation focused on brain tumors | Commercial Services |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
ChemGenex Therapeutics, Inc. | |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valent Technologies LLC | |
Edison Oncology Holding Corp.
Edison Oncology Holding Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for anti tumors | Health Technology |
NewGen Therapeutics, Inc.
 NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provide research and development services | Health Technology |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Health Technology |
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Operates as a expanded access platform for pharmaceutical manufactures | Technology Services |
